| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8216065 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 36 Pages |
Abstract
The combined molecular subtype-RSI identified a novel molecular subpopulation (TN and radioresistant) with an increased risk of LR after breast-conserving therapy. We propose that the combination of RSI and molecular subtype could be useful in guiding radiation therapy-based decisions in breast cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Javier F. MD, William J. MS, Jimmy J. MD, PhD, Nicolas MS, Marc A. MD, PhD, Marc MD, PhD, Arash O. MD, Eleanor E. MD, Steven A. PhD,